Illumina $750 million revolving credit facility
We advised the agents and joint lead arrangers on the financing
Davis Polk advised the agents and joint lead arrangers in connection with a $750 million unsecured revolving credit facility for Illumina, Inc. The proceeds of the loans will be used to finance working capital needs and for general corporate purposes.
Based in San Diego, California, Illumina is the global leader in sequencing- and array-based solutions for genetic analysis. Its products and services serve customers in a wide range of markets, enabling the adoption of genomic solutions in research and clinical settings. Illumina’s common stock is listed on the Nasdaq Global Select Market under the symbol “ILMN.”
The Davis Polk finance team included partner Jeong M. Lee, counsel Ilona C. Potiha and associates William Son, Scott G. Johnsson and Sarah Hylton. Counsel Kiara L. Rankin and associate Tomislava Dragicevic provided tax advice. Partner Adam Kaminsky and counsel Gregory D. Hughes provided executive compensation advice. Partner John B. Reynolds III and associate Charles Klug provided sanctions advice. Counsel David A. Zilberberg provided environmental advice. Members of the Davis Polk team are based in the New York, Washington DC and Northern California offices.
Copy link to share post